78 patents currently held
63 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Jan 2027. from the record
Of the 63 now held by other companies, 33 name Ohio State Innovation Foundation as their current owner, and 30 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
29
Ending by 2030
Jan 2027
Next term end
67
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Mar 2034 · Low confidence
Also notable
Ends Jul 2038 · High confidence
Also notable
Ends Jan 2027 · Medium confidence
Also notable
Ends Apr 2031 · High confidence
Also notable
Ends Feb 2031 · High confidence
Also notable
Ends Dec 2031 · High confidence
Also notable
Ends Feb 2032 · High confidence
Also notable
Ends Mar 2031 · High confidence
Inhibitors of PRMT5 and Methods of Their Use
US 10,723,698
Granted 2020. Computed term ends 2034. A terminal disclaimer caps this term to an earlier patent's.
Methods of Treatment for Bacterial Infections
US 11,191,773
Granted 2021. Computed term ends 2038.
Methods for Diagnosing Colon Cancer Using Microrna Signatures
US 9,017,940
The largest patent family in this portfolio, 25 related applications, renewed at 3 of 3 maintenance windows. Protection runs to 2027. A terminal disclaimer caps this term to an earlier patent's.
Treatment of Metabolic-Related Disorders Using Hypothalamic Gene Transfer of BDNF and Compositions Therefor
US 9,265,843
Cited by 20 later US patents, top 25% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2031.
Primers and Methods for Nucleic Acid Amplification
US 9,499,860
Cited by 17 later US patents, top 25% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2031.
Methods and Systems for Synthesizing Iron-Based Materials and Sequestering Carbon Dioxide
US 8,974,757
Granted 2015 and renewed at every maintenance window due so far. Protection runs to 2031.
Methods for Identifying Fragile Histidine Triad (FHIT) Interaction and Uses Thereof
US 8,911,998
Renewed at every maintenance window since the 2014 grant; no more fees are due before its term ends in 2032.
Materials and Methods Related to Modulation of Mismatch Repair and Genomic Stability by miR-155
US 9,023,825
Renewed at every maintenance window since the 2015 grant; no more fees are due before its term ends in 2031.
Formerly held, still cited
Notable
Ends Jan 2027 · High confidence
The most cited patent in this portfolio, cited by 121 later US patents, top 5% of utility patents granted in 2012 in our data. Protection runs to 2027.
now held by The Ohio State University Research Foundation
Also notable
Ends Nov 2031 · High confidence
Cited by 62 later US patents, top 5% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2031. A terminal disclaimer caps this term to an earlier patent's.
conveyed to Ohio State Innovation Foundation
Also notable
Ends May 2032 · High confidence
Cited by 29 later US patents, top 25% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
now held by RTX Corporation
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 4 fees due Dec 2 to 23, 2026 · next Dec 2
- 2 fees due Jan 9 to 14, 2027 · next Jan 9
- 1 fee due Mar 15, 2027The maintenance fee for Catalysts for Use in Electrochemical Applications and Electrodes and Devices Using Same (US 9,136,542) comes due Mar 15, 2027. Unpaid by Sep 15, 2027, it lapses early.
- 2 fees due Aug 2 to 23, 2027 · next Aug 2
- 2 fees due Sep 8 to 15, 2027 · next Sep 8
Recent changes
- 1 term has ended since Aug 21, 2026
What they patent
The largest of its 67 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,473,028 | Method and Device for Investigation of Phase Transformations in Metals and Alloys In force · High confidence | In force | High confidence | |
| US 9,017,939 | Methods for Diagnosing Breast, Colon, Lung, Pancreatic and Prostate Cancer Using miR-21 and miR-17-5p In force · Medium confidence | In force | Medium confidence | |
| US 9,017,940 | Methods for Diagnosing Colon Cancer Using Microrna Signatures In force · Medium confidence | In force | Medium confidence | |
| US 9,051,618 | Methods for Diagnosing Lung Cancer Using MicroRNA Signatures In force · High confidence | In force | High confidence | |
| US 7,488,462 | Multi-Stage Catalyst Systems and Uses Thereof In force · High confidence | In force | High confidence | |
| US 7,630,598 | Apparatus and Method for Providing an Optical Cross-Connect In force · High confidence | In force | High confidence | |
| US 7,633,670 | Methods, Systems, and Devices for Steering Optical Beams In force · High confidence | In force | High confidence | |
| US 7,921,949 | All Wheel Drive Electrically-Variable Transmission In force · High confidence | In force | High confidence | |
| US D685,268 | Spray Device In force · High confidence | In force | High confidence | |
| US 9,023,598 | Methods for Diagnosing Pancreatic Cancer Using MIR-103-1, MIR-103-2, MIR-24-2 and MIR-107 In force · High confidence | In force | High confidence |
Also on record, not counted in the 78: 63 patents in force now held by others · 117 patents ended · 8 applications pending · 139 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.